STUB1 and coronary artery disorder: In contrast, those who were CHIP+/AgeAccelHG− did not have elevated risk of either all‐cause mortality (HR 0.78, p < 0.20) or CHD (HR 1.03, p < 0.93) compared to those who were CHIP−/AgeAccelHG− (Figure 2B,C).